TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

1.43 Sort P et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis
and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403-9.
1.44 Bhuva M et al. Spontaneous bacterial peritonitis: an update on evaluation, management, and prevention.
Am J Med 1994;97:169-75.
1.45 Roehrborn A et al. The microbiology of postoperative peritonitis. Clin Infect Dis 2001;33:1513-9.
1.46 Seguin P et al. Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis
requiring intensive care. J Antimicrob Chemother 2010;65:342-6.
1.47 Montravers P et al. Clinical and microbiological profiles of community-acquired and nosocomial intraabdominal
infections: results of the French prospective, observational EBIIA study. J Antimicrob
Chemother 2009;63:785-94.
1.48 Eggimann P et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical
patients. Crit Care Med 1999;27:1066-72.
1.49 Wilson ML et al. Laboratory diagnosis of bone, joint, soft tissue, and skin infections. Clin Infect Dis
2008;46:453-7.
1.50 Pineda C et al. Imaging of osteomyelitis: current concepts. Infect Dis Clin North Am 2006;20:789-
825.
1.51 Lew DP et al. Osteomyelitis. Lancet 2004;364:369-79.
1.52 Lazzarini L et al. Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical
trials? Int J Infect Dis 2005;9:127-38.
1.53 Calhoun JH et al. Adult osteomyelitis. Infect Dis Clin North Am 2005;19:765-86.
1.54 Landersdorfer CB et al. Penetration of antibacterials into bone: pharmacokinetic, pharmaco-dynamic
and bioanalytical considerations. Clin Pharmacokinet 2009;48:89-124.
1.55 Ferroni A. Epidémiologie et diagnostic bactériologique des infections ostéoarticulaires aiguës de l'enfant.
Arch Pediatr 2007;14(suppl. 2):S91-6.
1.56 Kaplan SL. Osteomyelitis in children. Infect Dis Clin North Am 2005;19:787-97.
1.57 Harik NS et al. Management of acute hematogenous osteomyelitis in children. Expert Rev Anti Infect
Ther 2010;8:175-81.
1.58 Dessí A et al. Osteo-articular infections in newborns: diagnosis and treatment. J Chemother 2008;
20:542-50.
1.59 Ecury-Goossen GM et al. Sequential intravenous-oral antibiotic therapy for neonatal osteomyelitis.
Pediatr Infect Dis J 2009;28:72-3.
1.60 Chometon S et al. Specific real-time polymerase chain reaction places Kingella kingae as the most
common cause of osteoarticular infections in young children. Pediatr Infect Dis J 2007;26:377-81.
1.61 Darouiche RO. Spinal epidural abscess. N Engl J Med 2006;355:2012-20.
1.62 Weichert S et al. Acute haematogenous osteomyelitis in children: is there any evidence for how long
we should treat? Curr Opin Infect Dis 2008;21:258-62.
1.63 Zaoutis T et al. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for
acute osteomyelitis in children. Pediatrics 2009;123:636-42.
1.64 Velissariou IM. The use of fluoroquinolones in children: recent advances. Expert Rev Anti Infect
Ther 2006;4:853-60.
1.65 Zimmerli W. Vertebral osteomyelitis. N Engl J Med 2010;362:1022-9.
1.66 Marculescu CE et al. Outcome of prosthetic joint infections treated with debridement and retention of
components. Clin Infect Dis 2006;42:471-8.
1.67 Kowalski TJ et al. The management and outcome of spinal implant infections: contemporary retrospective
cohort study. Clin Infect Dis 2007;44:913-20.
1.68 Senneville E et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis:
concordance with ulcer swab cultures. Clin Infect Dis 2006;42:57-62.
1.69 Lewis JS et al. Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists
be concerned? Clin Infect Dis 2005;40:280-5.
1.70 Dohin B et al. Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus
aureus. Pediatr Infect Dis J 2007;26:1042-8.
1.71 Lovering AM et al. Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing
routine hip replacement. J Antimicrob Chemother 2002;50:73-7.
1.72 Dohin B et al. Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive
Staphylococcus aureus. Pediatr Infect Dis J 2007;26:1042-8.
1.73 Paviour S et al. Corynebacterium species isolated from patients with mastitis. Clin Infect Dis 2002;
35:1434-40.
1.74 Moazzez A et al. Breast abscess bacteriologic features in the era of community-acquired methicillinresistant
Staphylococcus aureus epidemics. Arch Surg 2007;142:881-4.
1.75 Araco A et al. Infections of breast implants in aesthetic breast augmentations: a single-center review
of 3,002 patients. Aesthetic Plast Surg 2007;31:325-9.
1.76 Pittet B et al. Infection in breast implants. Lancet Infect Dis 2005;5:94-106.
1.77 Lu CH et al. Strategies for the management of bacterial brain abscess. J Clin Neurosci 2006;13:
979-85.
1.78 Hakan T et al. Bacterial brain abscesses: an evaluation of 96 cases. J Infect 2006;52:359-66.
1.79 Tonon E et al. Brain abscess: clinical aspects of 100 patients. Int J Infect Dis 2006;10:103-9.
1.80 Roche M et al. A twelve-year review of central nervous system bacterial abscesses; presentation and
aetiology. Clin Microbiol Infect 2003;9:803-9.
1.81 de Oliveira Penido N et al. Intracranial complications of otitis media: 15 years of experience in 33 patients.
Otolaryngol Head Neck Surg 2005;132:37-42.
1.82 McClelland S et al. Postoperative central nervous system infection: incidence and associated factors
in 2111 neurosurgical procedures. Clin Infect Dis 2007;45:55-9.
1.83 Bayston R et al. Use of antibiotics in penetrating craniocerebral injuries. Lancet 2000;355:1813-7.
1.84 Brown-Elliott BA et al. Clinical and laboratory features of the Nocardia spp. based on current molecular
taxonomy. Clin Microbiol Rev 2006;19:259-82.
1.85 Hitti W et al. Two cases of multidrug-resistant Nocardia farcinica infection in immunosuppressed patients
and implications for empiric therapy. Eur J Clin Microbiol Infect Dis 2005;24:142-4.
1.86 Gomez-Flores A et al. In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis.
Antimicrob Agents Chemother 2004;48:832-7.
1.87 Ntziora F et al. Linezolid for the treatment of patients with central nervous system infection. Ann
Pharmacother 2007;41:296-308.
1.88 Jodlowski TZ et al. Linezolid for the treatment of Nocardia spp. infections. Ann Pharmacother 2007;
41:1694-9.